Literature DB >> 18323479

Cerebrospinal fluid tenascin-C increases preceding the development of chronic shunt-dependent hydrocephalus after subarachnoid hemorrhage.

Hidenori Suzuki, Noriaki Kinoshita, Kyoko Imanaka-Yoshida, Toshimichi Yoshida, Waro Taki.   

Abstract

BACKGROUND AND
PURPOSE: The possible cause of chronic hydrocephalus after subarachnoid hemorrhage (SAH) has been reported to be meningeal fibrosis. We examined whether the induction of tenascin-C (TN-C), an extracellular matrix glycoprotein known to promote tissue fibrosis, was associated with chronic hydrocephalus after SAH.
METHODS: We prospectively measured cerebrospinal fluid TN-C levels in 7 control patients with unruptured cerebral aneurysms and in 29 consecutive patients with aneurysmal SAH on days 1 to 12.
RESULTS: Cerebrospinal fluid TN-C levels were less than the diagnostic threshold level in control patients but markedly increased after SAH. Higher TN-C levels were observed in patients with more severe SAH on admission CT, ventricular drainage for acute obstructive hydrocephalus, and a worse outcome. Independent of these factors, however, cerebrospinal fluid TN-C levels were significantly higher in patients with than without subsequent chronic shunt-dependent hydrocephalus on days 1 to 9.
CONCLUSIONS: These findings suggest the possible involvement of TN-C in the development of chronic hydrocephalus after SAH and encourage further studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18323479     DOI: 10.1161/STROKEAHA.107.505735

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

Review 2.  Cerebrospinal fluid predictors of shunt-dependent hydrocephalus after hemorrhagic stroke: a systematic review and meta-analysis.

Authors:  Yao-Chung Yang; Szu-Hao Liu; Yu-Hone Hsu; Yu-Lun Wu; Ping-Teng Chu; Pei-Chin Lin
Journal:  Neurosurg Rev       Date:  2022-01-11       Impact factor: 3.042

3.  Deficiency of Tenascin-C Alleviates Neuronal Apoptosis and Neuroinflammation After Experimental Subarachnoid Hemorrhage in Mice.

Authors:  Lei Liu; Masashi Fujimoto; Fumi Nakano; Hirofumi Nishikawa; Takeshi Okada; Fumihiro Kawakita; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Hidenori Suzuki
Journal:  Mol Neurobiol       Date:  2018-03-15       Impact factor: 5.590

4.  High fibrosis indices in cerebrospinal fluid of patients with shunt-dependent post-traumatic chronic hydrocephalus.

Authors:  Xu Hao; Wang Junwen; Li Jiaqing; Li Ran; Zhang Zhuo; Huang Yimin; Jiao Wei; Sun Wei; Lei Ting
Journal:  Transl Neurosci       Date:  2016-09-09       Impact factor: 1.757

Review 5.  The Role of Tenascin-C in Tissue Injury and Repair After Stroke.

Authors:  Takeshi Okada; Hidenori Suzuki
Journal:  Front Immunol       Date:  2021-01-21       Impact factor: 7.561

Review 6.  Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment.

Authors:  Zaixiang Fu; Ganggui Zhu; Chao Luo; Zihang Chen; Zhangqi Dou; Yike Chen; Chen Zhong; Sheng Su; Fuyi Liu
Journal:  Front Oncol       Date:  2022-08-12       Impact factor: 5.738

Review 7.  The Pathogenesis of Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage.

Authors:  Lu-Ting Kuo; Abel Po-Hao Huang
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

8.  Tenascin-C in aneurysmal subarachnoid hemorrhage: deleterious or protective?

Authors:  Hidenori Suzuki; Fumihiro Kawakita
Journal:  Neural Regen Res       Date:  2016-02       Impact factor: 5.135

Review 9.  Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH).

Authors:  Shafqat Rasul Chaudhry; Ahmad Hafez; Behnam Rezai Jahromi; Thomas Mehari Kinfe; Alf Lamprecht; Mika Niemelä; Sajjad Muhammad
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.